Abstract
Adrienne Lesley Edkins, Özlem Taştan Bishop
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
MDM-TASK-web: MD-TASK and MODE-TASK web server for analyzing protein dynamics
2021 · 54 citations
Novel dynamic residue network analysis approaches to study allosteric modulation: SARS-CoV-2 M pro and its evolutionary mutations as a case study
2021 · 29 citations
Allosteric pockets and dynamic residue network hubs of falcipain 2 in mutations including those linked to artemisinin resistance
2021 · 0 citations
No local citing links have been materialized yet.
COVID-19 infection: emergence, transmission, and characteristics of human coronaviruses
10.1016/j.jare.2020.03.005 · 2020
10.1038/s12276-021-00604-z
10.1038/s12276-021-00604-z
Unresolved referenced work
Kept as external metadata until matched
10.1038/s41586-020-2008-3
10.1038/s41586-020-2008-3
10.1038/s41586-020-2012-7
10.1038/s41586-020-2012-7
10.1038/s41586-020-2180-5
10.1038/s41586-020-2180-5
10.1016/j.jiph.2021.06.007
10.1016/j.jiph.2021.06.007
10.1056/nejmoa1211721
10.1056/nejmoa1211721
Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants
10.1016/j.jbc.2021.101208 · 2021
10.3390/ijms22063060
10.3390/ijms22063060
10.1016/j.chom.2021.06.006
10.1016/j.chom.2021.06.006
10.1039/d1ra04694b
10.1039/d1ra04694b
10.1016/j.cell.2021.02.037
10.1016/j.cell.2021.02.037
Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool
10.1093/ve/veab064 · 2021
10.1056/nejmsr2105280
10.1056/nejmsr2105280
10.1038/s41564-021-00932-w
10.1038/s41564-021-00932-w
Emerging SARS-CoV-2 variants of concern and potential intervention approaches
10.1186/s13054-021-03662-x · 2021
10.1002/jmv.27541
10.1002/jmv.27541
Emerging vaccine-breakthrough SARS-CoV-2 variants
2021
10.1016/j.chom.2021.01.014
10.1016/j.chom.2021.01.014
10.1016/j.cell.2021.03.013
10.1016/j.cell.2021.03.013
10.1038/s41591-021-01347-0
10.1038/s41591-021-01347-0
10.1016/j.cell.2021.03.036
10.1016/j.cell.2021.03.036
10.1016/s0092-8674(03)00976-0
10.1016/s0092-8674(03)00976-0
10.1016/j.bbrc.2020.02.071
10.1016/j.bbrc.2020.02.071
10.1128/jvi.00127-20
10.1128/jvi.00127-20
Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
10.1007/s12041-021-01262-w · 2021
10.1016/j.bbrc.2020.05.028
10.1016/j.bbrc.2020.05.028
10.1038/s41401-020-0485-4
10.1038/s41401-020-0485-4
10.1126/science.1116480
10.1126/science.1116480
10.1111/j.1742-4658.2005.04756.x
10.1111/j.1742-4658.2005.04756.x
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9
10.1161/01.res.87.5.e1 · 2000
ACE2, a new regulator of the renin-angiotensin system
10.1016/j.tem.2004.03.001 · 2004
10.1002/path.2162
10.1002/path.2162
10.1074/jbc.m311191200
10.1074/jbc.m311191200
Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence
10.1021/bi035268s · 2003
10.1056/nejmoa2029849
10.1056/nejmoa2029849
10.1038/s41586-020-2571-7
10.1038/s41586-020-2571-7
10.1016/j.scr.2020.102125
10.1016/j.scr.2020.102125
10.1038/s41551-020-00660-2
10.1038/s41551-020-00660-2
E484K and N501Y SARS-CoV 2 spike mutants Increase ACE2 recognition but reduce affinity for neutralizing antibody
10.1016/j.intimp.2021.108424 · doi-reference
10.1101/2022.01.24.477633
10.1101/2022.01.24.477633 · doi-reference
10.1016/j.bbrc.2021.12.079
10.1016/j.bbrc.2021.12.079 · doi-reference
10.1038/s41586-021-04245-0
10.1038/s41586-021-04245-0 · doi-reference
10.1007/s00249-019-01384-1
10.1007/s00249-019-01384-1 · doi-reference
10.1371/journal.pcbi.1008790
10.1371/journal.pcbi.1008790 · doi-reference
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
10.1186/s13073-021-00985-w · doi-reference
10.1101/2021.12.14.472585
10.1101/2021.12.14.472585 · doi-reference
10.1126/science.abb2762
10.1126/science.abb2762 · doi-reference
10.3390/v12050497
10.3390/v12050497 · doi-reference
Laplacian centrality: a new centrality measure for weighted networks
10.1016/j.ins.2011.12.027 · doi-reference
10.1002/1873-3468.14076
10.1002/1873-3468.14076 · doi-reference
10.7554/elife.69091
10.7554/elife.69091 · doi-reference
10.1002/jcp.30367
10.1002/jcp.30367 · doi-reference
10.1021/acsnano.0c04674
10.1021/acsnano.0c04674 · doi-reference
10.1080/07391102.2020.1837676
10.1080/07391102.2020.1837676 · doi-reference
10.1016/j.jaim.2020.05.009
10.1016/j.jaim.2020.05.009 · doi-reference
Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach
10.5339/qmj.2021.12 · doi-reference
10.1002/slct.202101852
10.1002/slct.202101852 · doi-reference
Molecular docking and dynamics studies to explore effective inhibitory peptides against the spike receptor binding domain of SARS-CoV-2
10.3389/fmolb.2021.791642 · doi-reference
In silico screening of bioactive compounds of representative seaweeds to inhibit SARS-CoV-2 ACE2-bound omicron B.1.1.529 spike protein trimer
10.3390/md20020148 · doi-reference
10.3390/molecules26020406
10.3390/molecules26020406 · doi-reference
10.1101/2021.10.27.465996
10.1101/2021.10.27.465996 · doi-reference
10.1126/sciadv.abb8097
10.1126/sciadv.abb8097 · doi-reference
10.1140/epjb/e2004-00111-4
10.1140/epjb/e2004-00111-4 · doi-reference
Betweenness centrality and resistance distance in communication networks
10.1109/mnet.2010.5634437 · doi-reference
10.26434/chemrxiv-2021-7thm1
10.26434/chemrxiv-2021-7thm1 · doi-reference
Principles of protein-protein interactions
10.1073/pnas.93.1.13 · doi-reference
10.1074/jbc.m502486200
10.1074/jbc.m502486200 · doi-reference
10.1080/07391102.2020.1802348
10.1080/07391102.2020.1802348 · doi-reference
10.1074/jbc.ra120.015303
10.1074/jbc.ra120.015303 · doi-reference
10.1093/jb/mvab041
10.1093/jb/mvab041 · doi-reference
10.3390/cells10030506
10.3390/cells10030506 · doi-reference
10.1073/pnas.1609780113
10.1073/pnas.1609780113 · doi-reference
10.1016/s1074-7613(00)00061-3
10.1016/s1074-7613(00)00061-3 · doi-reference
The pH effects on SARS-CoV and SARS-CoV-2 spike proteins in the process of binding to hACE2
10.3390/pathogens11020238 · doi-reference
10.1016/s0140-6736(21)02758-6
10.1016/s0140-6736(21)02758-6 · doi-reference
10.1093/nar/gkt376
10.1093/nar/gkt376 · doi-reference
10.1093/nar/gkz397
10.1093/nar/gkz397 · doi-reference
10.1093/nar/gkh468
10.1093/nar/gkh468 · doi-reference